Please wait
 

Exhibit 107
Calculation of Filing Fee Tables
 
Form 424(b)(5) 
(Form Type)
 
ATAI Life Sciences N.V.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
             
 
Security
Type
Security Class Title
Fee Calculation
or Carry
Forward Rule
Amount
Registered
Proposed
Maximum
Offering Price Per
Unit
Maximum
Aggregate
Offering Price
Fee Rate
Amount of
Registration
Fee
Carry
Forward
Form
Type
Carry
Forward
File
Number
Carry
Forward
Initial
Effective
Date
Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
Be Carried
Forward
Newly Registered Securities
Fees to Be Paid
Equity
Common shares, par value €0.10 per share
Rule 457(r) (1)
27,283,750 (2)
$5.48
$149,514,950.00
0.00013810
$20,648.01
Carry Forward Securities
Carry Forward Securities
 
Total Offering Amounts
 
$149,514,950.00
 
$20,648.01
       
 
Total Fees Previously Paid
     
       
 
Total Fee Offsets
     
       
 
Net Fee Due
     
$20,648.01
       
 
 
(1)Calculated in accordance with Rules 457(r) and 456(b) of the Securities Act of 1933, as amended. This “Calculation of Filing Fee Tables” shall be deemed to update the “Calculation of Filing Fee Tables” in the registrant’s registration statement on Form S-3 filed with the U.S. Securities and Exchange Commission on September 29, 2025 (File No. 333-290592).
(2)Represents 27,283,750 common shares (inclusive of the 30-day option for the underwriters to purchase up to an additional 3,558,750 shares), par value €0.10 per share, of ATAI Life Sciences N.V. that will be offered for sale pursuant to the prospectus supplement to which this exhibit is attached.
 

424B5 Common shares, par value Euro0.10 per share N/A 0001840904 EX-FILING FEES S-3 N/A 0001840904 2025-10-17 2025-10-17 0001840904 1 2025-10-17 2025-10-17 xbrli:shares iso4217:USD xbrli:shares iso4217:USD xbrli:pure